Biotech company Regeneron to buy bankrupt 23andMe for $256M

Photo credit: John Murphy via Flickr. CC BY-SA 2.0. Article by Beth Mole. Ars Technica – May 19, 2025.

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company running without interruption and uphold its privacy-protection promises. In its announcement of the acquisition, Regeneron assured 23andMe’s 15 million customers that their data—including genetic and health information, genealogy, and other sensitive personal information—would be safe and in good hands. […]

Click here to view original web page at www.arstechnica.com